Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
188.8M
Cash
18.53M
Avg Qtr Burn
-3.062M
Short % of Float
12.75%
Insider Ownership
45.35%
Institutional Own.
6.96%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NXP800 Details Ovarian cancer, Cancer | Phase 1b Data readout | |
NXP900 Details YES1/SRC-driven solid tumors, Non-small cell lung cancer | Phase 1b Initiation | |
NXP800 Details Cholangiocarcinoma | Phase 1 Data readout |